Tag: Patents
Patents on Inhaler Devices Can’t Block Generics: Federal Circuit Clarifies Orange Book Listings
December 20, 2024
Teva Branded Pharm. Prods. R&D, Inc. v. Amneal Pharms. of N.Y., LLC Authored by: Jeremy J. Gustrowsky A recent Federal Circuit decision has big implications for pharmaceutical companies that make combination drug-device products, like inhalers. The court ruled that patents…
Read MoreFederal Circuit Affirms No Infringement in Oracea® Generic Patent Dispute
December 6, 2024
Galderma Labs., L.P. v. Lupin Inc Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit affirmed that Lupin Inc.’s proposed generic version of Oracea® does not infringe Galderma Laboratories’ patents covering the branded drug. Oracea® is a…
Read MoreFederal Circuit Clarifies When Inherency Makes Patent Claims Obvious in Cytiva v. JSR
December 4, 2024
Cytiva BioProcess R&D AB v. JSR Corp Authored by: Jeremy J. Gustrowsky In a significant decision for biotechnology patents, the Federal Circuit recently addressed the concept of inherency in obviousness determinations in Cytiva BioProcess R&D AB v. JSR Corp. The…
Read MoreFacebook Defeats Patent Claims Over News Feed and Timeline Features
December 4, 2024
Mirror Worlds Techs., LLC v. Meta Platforms, Inc Authored by: Jeremy J. Gustrowsky A recent Federal Circuit decision has closed the book on a long-running patent dispute between Mirror Worlds Technologies, LLC and Meta Platforms, Inc. (formerly Facebook, Inc.), with…
Read MoreWhen Is a “Single Action” Not Enough? Federal Circuit Clarifies Doctrine of Equivalents Proof Requirements
October 24, 2024
Nexstep, Inc. v. Comcast Cable Commc’ns, LLC Authored by: Jeremy J. Gustrowsky A recent Federal Circuit decision has clarified the high bar for proving patent infringement under the doctrine of equivalents, especially when the technology at issue seems simple. The…
Read MoreForeign Antisuit Injunctions in SEP Disputes: Federal Circuit Clarifies When U.S. Courts Can Step In
October 24, 2024
Telefonaktiebolaget LM Ericsson v. Lenovo (United States), Inc Authored by: Jeremy J. Gustrowsky A recent Federal Circuit decision sheds light on when U.S. courts can stop companies from enforcing foreign patent injunctions in global disputes over standard-essential patents (SEPs –…
Read MoreFederal Circuit Clarifies Double Patenting and Written Description in Allergan v. MSN Labs
October 8, 2024
Allergan USA, Inc. v. MSN Labs. Priv. Ltd Authored by: Jeremy J. Gustrowsky In a significant decision for pharmaceutical patent holders, the Federal Circuit reversed a district court’s ruling that had invalidated several Allergan patents related to the drug eluxadoline,…
Read MoreFalse “Patented” Claims Can Violate the Lanham Act, Says Federal Circuit in Crocs v. Effervescent
October 3, 2024
Crocs, Inc. v. Effervescent, Inc Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit clarified that companies can be held liable under the Lanham Act for falsely advertising their products as “patented” when those claims mislead consumers…
Read MoreFederal Circuit Admonishes District Court for Deciding Patent Eligibility Issue That Neither Party Raised
September 18, 2024
Astellas Pharma, Inc. v. Sandoz Inc Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit vacated a district court ruling that had invalidated key claims of Astellas Pharma’s patent for its overactive bladder drug, Myrbetriq® (U.S. Patent…
Read MorePatent Claims Don’t Have to Be Mutually Exclusive, Says Appeals Court in Catheter Patent Dispute
September 16, 2024
Vascular Sols. LLC v. Medtronic, Inc Authored by: Jeremy J. Gustrowsky A recent decision from the Federal Circuit offers important guidance for patent owners and litigants about how patent claims can be drafted and interpreted—especially when it comes to claims…
Read MorePatent Claims for Action Cameras Survive Eligibility Challenge in Contour v. GoPro
September 9, 2024
Contour IP Holding LLC v. GoPro, Inc Authored by: Jeremy J. Gustrowsky In a significant decision for technology innovators, the Federal Circuit reversed a lower court’s ruling that had invalidated Contour IP Holding LLC’s patents covering point-of-view (POV) action cameras,…
Read MoreFederal Circuit Revives ParkerVision’s Patent Claims Against Qualcomm Over Wireless Chip Technology
September 6, 2024
Parkervision, Inc. v. Qualcomm Inc Authored by: Jeremy J. Gustrowsky A recent decision by the Federal Circuit has breathed new life into ParkerVision’s long-running patent dispute with Qualcomm over wireless communication technology. The court found that the lower district court…
Read More